We found only two studies demonstrated the better effect of NACA compared to NAC: in vitro in human hepatoma HepaRG cells (Tobwala et al., 2015) and in vivo in mice (Khayyat et al., 2016), but none has been published in humans yet. The gene discussed is NACA; the disease is hepatocellular carcinoma.